Incyte Corporation
$125.01
+1.79 (+1.45%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +5.6%
- 3 Months
- +35.5%
- YTD
- +26.6%
- 1 Year
- +47.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 33.0%
- Largest decline max drawdown, since Aug 2025
- -18.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.35
Own INCY?
See how INCY contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.